FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Authority Hl7

42,405 resources

Type: Text:

By Version

By Realm

 

Start Prev Rows 32800 - 33000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealm
hl7.terminologyR5ValueSet/v3-PersonalAndLegalRelationshipRoleTypePersonalAndLegalRelationshipRoleTypeactive2023-06uv
de.basisprofil.r4R4ValueSet/valueset-wg14WG14 ValueSetactive2025-06
HIE2.packagesR4ValueSet/results-laboratory-blood-abo-rh-grp-gps-uv-ipsResults Laboratory ABO+RH Group (GPS) - IPSactive2022-01uv
hl7.fhir.us.registry-protocolsR4ValueSet/LesionComplexityComplexity of the Lesionactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/CABGIndicationCABG Indicationactivecic2023-11us
hl7.fhir.us.medmorphR4ValueSet/us-ph-computable-valueset-exampleUS Public Health Computable ValueSet Exampledraft2022-07us
hl7.fhir.us.ecrR4ValueSet/us-ph-computable-valueset-exampleUS Public Health Computable ValueSet Exampledraft2022-05us
hl7.fhir.us.ph-libraryR4ValueSet/us-ph-valueset-computable-exampleUS Public Health ValueSet - Computable Exampledraft2022-07us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1562-laterality-from-landmarkRDE1562 Laterality from landmarkdraft2022-10us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1565-typeRDE1565 Typedraft2022-10us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1568-distributionRDE1568 Distributiondraft2022-12us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1571-associated-featuresRDE1571 Associated featuresdraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1576-shapeRDE1576 Shapedraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1577-typeRDE1577 Typedraft2022-10us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1578-densityRDE1578 Densitydraft2022-10us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1579-marginRDE1579 Margindraft2022-10us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1580-orientationRDE1580 Orientationdraft2022-10us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1586-assessment-categoryRDE1586 Assessment categorydraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1587-breast-composition-categoryRDE1587 Breast composition categorydraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1588-breast-lateralityRDE1588 Breast lateralitydraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1589-implant-presenceRDE1589 Implant presencedraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1590-prior-mastectomyRDE1590 Prior mastectomydraft2022-11us
hl7.fhir.us.breast-radiologyR4ValueSet/rde1602-typeRDE1602 Typedraft2022-12us
hl7.fhir.it.lab-reportR4ValueSet/aifa-aicAIFA AICactive2024-03it
hl7.fhir.it.terminologyR4ValueSet/aifa-geAIFA Gruppo di Equivalenzaactive2025-06it
hl7.org.nz.fhir.ig.formularyR4BValueSet/atc-codeATC codesactive2025-08nz
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.5.4--20200901000000AanduidingBijNummerCodelijstactivenl
hl7.terminologyR5ValueSet/verificationresult-can-push-updatesCan-push-updatesactivepa2024-04uv
ca.on.oh-olisR4ValueSet/olis-InterpretationProviderInterpretationactive
hl7.fhir.us.breast-radiologyR4ValueSet/rde1556-presenceRDE1556 Presencedraft2022-12us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1206.34AbnormalityOfGaitAndMobilityactive2021-07us
HIE2.packagesR4ValueSet/absent-or-unknown-allergies-uv-ipsAbsent or Unknown Allergies - IPSactive2022-01uv
hl7.cda.uv.ipsR4ValueSet/2.16.840.1.113883.11.22.61--20180127221947Absent or Unknown Devicesdraft2024-08uv
HIE2.packagesR4ValueSet/absent-or-unknown-immunizations-uv-ipsAbsent or Unknown Immunization - IPSactive2022-01uv
HIE2.packagesR4ValueSet/absent-or-unknown-medications-uv-ipsAbsent or Unknown Medication - IPSactive2022-01uv
HIE2.packagesR4ValueSet/absent-or-unknown-problems-uv-ipsAbsent or Unknown Problems - IPSactive2022-01uv
hl7.eu.fhir.pcspR4ValueSet/absent-or-unknown-procedures-uv-ipsAbsent or Unknown Procedures - IPStrial-use22022-11eu
hl7.fhir.us.mcodeR4ValueSet/mcode-tumor-size-units-vsTumor Size Units Value Setactive3cic2025-02us
hl7.terminologyR5ValueSet/cql-access-modifierCQL Access Modifierdraftcds2024-02uv
hl7.terminologyR5ValueSet/v3-ActEncounterAccommodationCodeActEncounterAccommodationCodeactive2014-03uv
hl7.terminologyR5ValueSet/v3-AcknowledgementConditionAcknowledgementConditionactive2014-03uv
hl7.terminologyR5ValueSet/v3-AcknowledgementTypeAcknowledgementTypeactive2014-03uv
ee.hl7.fhir.base.r5R5ValueSet/ee-act-priorityAct Prioritydraft2023-08ee
ee.fhir.terminologyR5ValueSet/act-priorityAct Priorityactive2025-06ee
hl7.terminologyR5ValueSet/v3-ActConsentDirectiveTypeActConsentDirectiveTypeactivesec2019-03uv
hl7.terminologyR5ValueSet/v3-ActConsentDirectiveActConsentDirectiveactive2014-03uv
hl7.terminologyR5ValueSet/v3-ActPrivacyLawActPrivacyLawactive2014-03uv
hl7.terminologyR5ValueSet/v3-ActPrivacyPolicyActPrivacyPolicyactive2014-03uv
hl7.terminologyR5ValueSet/v3-ActInformationSensitivityPolicyActInformationSensitivityPolicyactive2014-03uv
hl7.cda.uv.ipsR4ValueSet/2.16.840.1.113883.11.22.22--20170502000000ActStatusActiveCompletedAbortedCancelleddraft2024-08uv
hl7.cda.uv.ipsR4ValueSet/2.16.840.1.113883.11.22.12--20170330000000ActStatusActiveCompletedAbortedSuspendeddraft2024-08uv
ch.fhir.ig.ch-termR4ValueSet/ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeactive2025-05ch
signal.core.r4R4ValueSet/questionnaire-ccars-action-typesQuestionnaire CCARS Action Typesdraft1paus
hl7.terminologyR5ValueSet/adverse-event-clinical-research-seriousness-criteriaAdverse Event Clinical Research Seriousness Criteriaactive1brr2023-07uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/vs-action-selection-behavior-requiredAction Selection Behavior Requireddraft2022-11uv
hl7.terminologyR5ValueSet/v3-ActAdjudicationResultActionCodeActAdjudicationResultActionCodeactive2014-03uv
hl7.fhir.nl.zorgviewerR3ValueSet/ACPTreatmentCodelistACP behandelingen waardelijstactive2025-08nl
hl7.fhir.uv.cpgR4ValueSet/cpg-active-condition-vsCPG Active Condition Value Setactivecds2024-11uv
fhir.cqf.commonR4ValueSet/active-conditionCQF Active Conditionactive2019-07us
hl7.eu.fhir.pcspR4ValueSet/activeResolved-condition-vsActive or resolved Conditiondraft2025-08eu
ch.fhir.ig.ch-termR4ValueSet/ActivePharmaceuticalIngredientActivePharmaceuticalIngredientactive2025-05ch
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20200901000000ActiviteitCodelijstactivenl
hl7.fhir.us.vrdrR4ValueSet/vrdr-activity-at-time-of-death-vsActivity at Time of Death ValueSetactivepher2024-10us
ch.fhir.ig.ch-epr-fhirR4ValueSet/PpqmActorIdentifierTypeCH PPQm Actor Identifier Typeactive2025-05ch
ch.fhir.ig.ch-epr-ppqmR4ValueSet/PpqmActorIdentifierTypePPQm Actor Identifier Typeactive2023-12ch
hl7.fhir.us.nhsn-dqmR4ValueSet/ach-encounter-classAcute Care Hospital Encounter Class ValueSettrial-use1pher2025-07us
hl7.fhir.us.nhsn-dqmR4ValueSet/ach-encounter-statusAcute Care Hospital Encounter Status ValueSettrial-use1pher2025-07us
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-acute-grade-eu-pcspAcute Gvhd Gradedraft2025-08eu
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-chronic-grade-eu-pcspChronic Gvhd conditiondraft2025-08eu
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.10416Financially Responsible Party Type Value Setactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.20Telecom Use (US Realm Header)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19579Family Member Valueactive2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.38Smoking Statusactive2024-06us
hl7.fhir.uv.toolsR5ValueSet/additional-binding-purposeAdditional Binding Purpose ValueSetinformative4fhir2025-08uv
ch.fhir.ig.ch-termR4ValueSet/condition-categoryCondition Category Codesactive2025-05ch
hl7.fhir.uv.cardx-ciedR5ValueSet/cied-connectivity-state-modifier-vsCIED Connectivity Status Modifier Value Settrial-use2cic2025-07uv
ForgePatientChart.0830R4ValueSet/telus-address-stateTELUS ValueSet - Address Statedraft2020-11
hl7.fhir.us.davinci-crdR4ValueSet/locationAddressTypeCRD Location Address Types Value Settrial-use4fm2025-08us
ee.fhir.terminologyR5ValueSet/ads-adr-idADS AdrIdactive2025-06ee
ee.fhir.terminologyR5ValueSet/ads-oidADS Oidactive2025-06ee
hl7.fhir.us.davinci-hrexR4ValueSet/hrex-coverage-relationshipHRex Coverage Relationship ValueSetdraft0cic2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1032.313Statin Allergen Groupingactive2024-03us
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000AdemhalingScoreCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20200901000000AdemhalingsreactieCodelijstactivenl
hl7.fhir.uv.emedicinal-product-infoR5ValueSet/administrableDoseFormAdministrable Pharmaceutical Dose Formactive2025-07uv
hl7.terminologyR5ValueSet/v3-AdministrationDetectedIssueCodeAdministrationDetectedIssueCodeactive2014-03uv
ee.hl7.fhir.base.r5R5ValueSet/ee-administrative-genderAdministrative Genderdraft2023-08ee
ee.fhir.terminologyR5ValueSet/administrative-genderAdministrative Genderactive2025-06ee
ForgePatientChart.0830R4ValueSet/telus-administrative-genderTELUS ValueSet - Administrative Genderdraft2020-11
fhir.kisumuhieR4ValueSet/gender-vsGenderdraft2025-06us
fhir.kenyaPSIGR4ValueSet/administrative-gender-vsAdministrative Genderactive2025-07us
hl7.terminologyR5ValueSet/v3-xActEncounterReasonx_ActEncounterReasonactive2014-03uv
ca.ab.fhir.psabR4ValueSet/administrative-gender-abAdministrativeGender_ABdraft2024-06ca
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20200901000000AdresSoortCodelijstactivenl
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.645Pneumococcal Vaccine HD_CN_ Allergyactive2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.638b.well Adult Tetanus Vaccine CNactive2025-04us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.648bwell COVID Vaccine CN_Metactive2025-04us
hl7.eu.fhir.idea4rcR4ValueSet/adverse-event-type-eu-i4rcAdverse Event Typeactive2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/vs-affectedOrgan-eu-i4rcAffected Organs (surgery)active2025-07eu
hl7.eu.fhir.pcspR4ValueSet/vs-affectedOrgan-eu-pcspAffected Organs (surgery)draft2025-08eu
hl7.fhir.us.registry-protocolsR4ValueSet/YesNoYes or Noactivecic2023-11us
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000AfnameprocedureCodelijstactivenl
hl7.fhir.us.davinci-pdexR4ValueSet/ProvenanceAgentTypeProvenance Agent Typeinformativefm2025-06us
hl7.terminologyR5ValueSet/measure-aggregate-methodMeasure Aggregate Methodactivecqi2023-02uv
hl7.eu.fhir.idea4rcR4ValueSet/alcoholUsageStatus-athena-eu-i4rcAlcohol Usage Status: Athenaactive2025-07eu
hl7.eu.fhir.idea4rcR4ValueSet/alcoholUsageStatus-snomed-eu-i4rcAlcohol Usage Status: SNOMED CTactive2025-07eu
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000AlcoholGebruikStatusCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000AlertNaamCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000AlertTypeCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20200901000000AlertheidCodelijstactivenl
hl7.fhir.us.registry-protocolsR4ValueSet/StressTestCath PCI Selected Stress Testactivecic2023-11us
fhir.cdc.opioid-cds-r4R4ValueSet/barbiturate-medicationsBarbiturate Medicationsactive2025-02us
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-and-methadone-medicationsBuprenorphine and Methadone medicationsactive2023-05us
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-medicationsBuprenorphine Medicationsactive2025-02us
hl7.terminologyR5ValueSet/cpt-usableAMA CPT Usable Codesactivevocab2023-08uv
fhir.dicomR4ValueSet/allAll DICOM Controlled Terminology Definitionsactive2025-07us
hl7.v2plusR5ValueSet/data-typesv2DataTypestrial-useinm2025-08
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ISBTConvalescentPlasmaCodeVSISBT Convalescent Plasma Codesdraft2023-08us
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ISBTBloodProductCodeVSISBT Blood Product Codesdraft2023-08us
hl7.fhir.us.registry-protocolsR4ValueSet/SEattleAnginaQsSeattle Angina Questionsactivecic2023-11us
fhir.tx.support.r4R4ValueSet/covid-19-obsCOVID-19 related Observation codesdraft2020-03us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.13Screening and Assessment Survey Codesactive2024-10us
hl7.org.nz.fhir.ig.formularyR4BValueSet/NzmtCodesNZMT Codesactive2025-08nz
fhir.cdc.opioid-cds-r4R4ValueSet/oxycodone-medicationsOxycodone Medicationsactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.58Diabetes Medicationsactive2022-03us
fhir.tx.support.r4R4ValueSet/covid-19-condCOVID-19 related Condition codesdraft2020-03us
hl7.fhir.us.registry-protocolsR4ValueSet/HemodialysisOrPeritonealDialysishemodialysis or peritoneal dialysisactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacArrestCardiac Arrestactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/CABGCoronary artery bypass graftingactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/CerebrovascularDiseaseCerebrovascular Diseaseactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/PeripheralArterialOcclusiveDiseasePeripheral Arterial Occlusive Diseaseactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/DiabetesMellitusDiabetes Mellitusactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/DyslipidemiaDyslipidemiaactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/HeartFailureHeart Failure codes from SNOMEDactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/HypertensionHypertensionactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/PercutaneousCoronaryInterventionPCIactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/PriorCABGPrior History of Coronary Artery Bypass Graftactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/HypothermiaInducedInduced Hypothermia Codesactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/OrganDonorSNOMED Valueset of Organ Donor codesactivecic2023-11us
hl7.fhir.us.registry-protocolsR4ValueSet/AbnormalElectrocardiacAssessmentAbnormal Electrocardiac Assessmentactivecic2023-11us
fhir.cdc.opioid-cds-r4R4ValueSet/benzodiazepine-medicationsBenzodiazepine medicationsactive2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.230All Cancer Directed therapiesactive2024-05us
hl7.terminologyR5ValueSet/v3-IndividualCaseSafetyReportTypeIndividualCaseSafetyReportTypeactive2014-03uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/cochrane-picoCochrane PICOdraft2022-09uv
hl7.fhir.uv.sanerR4ValueSet/MeasureScoringMeasure Scoringactivepher2024-05uv
hl7.terminologyR5ValueSet/cpt-allAMA CPT All Codesactivevocab2023-08uv
hl7.terminologyR5ValueSet/cpt-baseAMA CPT Base Codesactivevocab2023-08uv
hl7.fhir.us.registry-protocolsR4ValueSet/FamilyPrematureCADFamily History of Premature CADactivecic2023-11us
hl7.fhir.uv.cqmR4ValueSet/iso-8601-derived-periodsISO-8601-Derived Periodstrial-use4cqi2025-06uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.158Multiple Myeloma Regimen Drugsactive2019-08us
hl7.fhir.uv.extensions.r4bR4BValueSet/all-resource-typesAll Resource Typesnormative5fhir2023-03uv
ee.hl7.fhir.base.r5R5ValueSet/ee-identity-systemIdentity Systemdraft2023-08ee
ee.fhir.terminologyR5ValueSet/identifier-domainIdentity Systemactive2025-06ee
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/cochrane-pico-interventionCochrane PICO Interventiondraft2022-09uv
hl7.eu.fhir.unicomR5ValueSet/language-bcp-vsLanguage (FHIR)draft2025-06eu
fhir.cdc.opioid-cds-r4R4ValueSet/naloxone-medicationsNaloxone medicationsactive2025-02us
fhir.cdc.opioid-cds-r4R4ValueSet/cdc-malignant-cancer-conditionsCDC malignant cancer conditionsactive2023-05us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.226Opioids, Allactive2024-01us
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-analgesics-with-ambulatory-misuse-potentialOpioid analgesics with ambulatory misuse potentialactive2025-02us
fhir.cdc.opioid-cds-r4R4ValueSet/extended-release-opioid-with-ambulatory-misuse-potentialExtended release opioid with ambulatory misuse potentialactive2025-02us
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/cochrane-pico-outcomeCochrane PICO Outcomedraft2022-09uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/cochrane-pico-populationCochrane PICO Populationdraft2022-09uv
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1053Carbidopa Levodopa Combination (RXNORM)active2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2362Tuberculosis (Ethambutol) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2363Tuberculosis (Isoniazid [INH]) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2364Tuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2365Tuberculosis (Rifabutin) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2366Tuberculosis (Rifampin) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2367Tuberculosis (Rifapentine) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.741Hepatitis B Immune Globulin (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.747Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)active2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.844Tuberculosis (Second Line Drugs for Treatment) (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.991Rifampin (RXNORM)active2024-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1594HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1595HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1597HIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1598HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1600HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1634Sofosbuvir Velpatasvir Combination (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1912Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1913Penicillin G [Procaine] [Injectable] (RXNORM)active2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1078Opioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1618Smallpox Vaccine (RXNORM)active2023-06us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2142Linezolid (RXNORM)active2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2143Tuberculosis (Pretomanid) (RXNORM)active2023-01us
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2144Tuberculosis (Bedaquiline) (RXNORM)active2023-01us
hl7.fhir.uv.extensions.r3R3ValueSet/FHIR-versionFHIRVersionnormative5vocab2023-03uv
hl7.terminologyR5ValueSet/v3-EntityClassMicroorganismEntityClassMicroorganismactive2014-03uv
hl7.fhir.uv.extensionsR5ValueSet/questionnaire-derivationTypeQuestionnaire Derivation Type Valuesetdraftfhir2025-08uv
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/vs-substances-snomedSubstances SNOMED CTdraft2022-09uv
de.basisprofil.r4R4ValueSet/UcumVitalsCommonDEUCUM Vitals Common DEactive2025-06
de.netzwerk-universitaetsmedizin.ebm-cpgR5ValueSet/vs-allergic-disposition-sctAllergic Disposition SCTdraft2022-09uv
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000AllergieCategorieCodelijstactivenl
nictiz.fhir.nl.r4.zib2020R4ValueSet/2.16.840.1.113883.2.4.3.11.60.40.2.8.2.3--20200901000000AllergieStatusCodelijstactivenl
hl7.fhir.be.allergyR4ValueSet/be-allergyintolerancecodeBeAllergyIntoleranceCodeactive2025-07be
hl7.fhir.eu.hdrR4ValueSet/allergy-intolerance-eu-hdrAllergy Intolerance (with exceptions)draft12025-06eu
hl7.fhir.eu.hdrR4ValueSet/allergy-intolerance-substances-eu-hdrAllergy Intolerancedraft12025-06eu
hl7.cda.uv.ipsR4ValueSet/2.16.840.1.113883.11.22.2--20161206000000Allergy or Intolerance Typedraft2024-08uv
hl7.fhir.uv.sanerR4ValueSet/MeasureStatusMeasure Status Valuesactivepher2024-05uv
hl7.fhir.us.davinci-crdR4ValueSet/configTypesCRD Configuration Code Data Types Value Settrial-use4fm2025-08us